Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on February ...
February 13 2018 - 4:05PM
Five Prime Therapeutics, Inc. (NASDAQ:FPRX), a clinical-stage
biotechnology company focused on discovering and developing
innovative immuno-oncology protein therapeutics, will report its
fourth quarter and full year 2017 financial results
on Tuesday, February 27, 2018, after
the U.S. financial markets close. Five Prime will host a
conference call and live audio webcast on Tuesday, February
27, 2018, at 4:30 p.m. (ET)/1:30 p.m. (PT) to discuss the
company's financial results and provide a general business update.
The live audio webcast may be accessed through the "Events &
Presentations" page in the "Investors" section of the company's
website at www.fiveprime.com. Alternatively, participants may dial
(877) 878-2269 (domestic) or (253) 237-1188 (international) and
refer to conference ID 7184787.
The archived conference call will be available on Five Prime's
website beginning approximately two hours after the event and will
be archived and available for replay for at least 30 days after the
event.
About Five Prime
Five Prime Therapeutics, Inc. discovers and develops innovative
therapeutics to improve the lives of patients with serious
diseases. Five Prime's comprehensive discovery platform, which
encompasses virtually every medically relevant extracellular
protein, positions it to explore pathways in cancer, inflammation
and their intersection in immuno-oncology, an area with significant
therapeutic potential and the focus of the company's R&D
activities. Five Prime has entered into strategic collaborations
with leading global pharmaceutical companies and has promising
product candidates in clinical and late preclinical development.
For more information, please visit www.fiveprime.com or
follow us on LinkedIn, Twitter and Facebook
CONTACT: Heather Rowe Senior Director, Investor
Relations and Corporate Communications 415-365-5737
heather.rowe@fiveprime.com
Five Prime Therapeutics (NASDAQ:FPRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Five Prime Therapeutics (NASDAQ:FPRX)
Historical Stock Chart
From Sep 2023 to Sep 2024